The longstanding adherence problem is yielding to new technology
Pharmaceutical Commerce - March 2019
A changing role for hubs in collecting critical data, raising adherence
Presidential campaigns only magnify an already intense debate
The goal of producing meaningful data is driving industry progress
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Lupin Invests $250 Million in New Coral Springs Manufacturing Facility to Bolster US Respiratory Drug Supply
2
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
3
